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Acrylamide is used extensively in sewage and wastewater 
treatment plants, in the paper and pulp industry, in treatment 
of potable water, and in research laboratories for chromatog- 
raphy, electrophoresis, and electron microscopy. Dermal contact 
is a major route of human exposure. It has been shown that 
acrylamide is highly effective in breaking chromosomes of germ 
cells of male mice and rats when administered intraperitoneally 
or orally, resulting both in the early death of conceptuses and 
in the transmission of reciprocal translocations to live-born 
progeny. It is now reported that acrylamide is absorbed through 
the skin of male mice, reaches the germ cells, and induces chro- 
mosomal damage. The magnitude of genetic damage appears to 
be proportional to the dose administered topically. o V?X Society 
of Toxicology. 
The skin does not serve as an effective barrier to all noxious 
chemicals. There are many cases in laboratory animals and 
in humans where chemicals were taken up through the skin 
and distributed throughout the body, giving rise to toxic ef- 
fects in various organs and tissues (see various reviews in 
Marzulli and Maibach, 1987). Additionally, dermal expo- 
sures of pregnant females to certain chemicals are known to 
cause embryotoxicity and congenital malformations in lab- 
oratory animals, and in some cases, similar effects are sus- 
pected in humans (Barlow, 1987). The possibility that the 
genetic integrity of the germ cells may be affected by mu- 
tagens absorbed through the skin has received little attention, 
even though dermal exposure is a common route of human 
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chemical exposure. A search of the literature turned up only 
one article (Brusick et al., 1982) reporting a germ cell mu- 
tagenicity test using skin painting as the exposure route. In 
this one case, a hair dye ingredient gave negative results in 
a mouse dominant lethal test. 
Our interest in conducting germ cell mutagenicity tests 
with acrylamide applied to the skin arose from (a) earlier 
studies which showed acrylamide to be an effective inducer 
of chromosomal damage in male mice following intraperi- 
toneal injections (Shelby et al., 1986, 1987) and in male rats 
following long-term oral administration (Smith et al., 1986) 
(b) the demonstration that acrylamide applied topically to 
mice was rapidly absorbed and distributed, binding to mac- 
romolecules in a variety of organs including testicular DNA 
(Carlson and Weaver, 1985), and (c)the fact that skin contact 
is a common route of human exposure to acrylamide. Re- 
ported here are the results of dominant lethal studies in mice 
demonstrating, for the first time, the accessibility and genetic 
vulnerability of mammalian germ cells to a chemical mu- 
tagen absorbed through the skin. 
METHODS 
Dominant lethal experiments were conducted on lo- to 12-week-old male 
(C3H/Rl X lOl/Rl)F, and female (C3H/Rl X C57Bl)Fr mice. All mice 
were bred and raised at the Oak Ridge National Laboratory, Biology Division, 
Mammalian Genetics and Development Section Research Animal Facility. 
They were caged in plastic boxes with kiln-dried pine shavings, fed Purina 
Lab Chow. and watered ad libitum. They were housed under daily 9-hr light 
(7:30 AM to 4:30 PM) and 15-hr dark periods. 
Acrylamide (399% purity) was obtained from Sigma Chemical Company, 
St. Louis, Missouri. The males were prepared for dermal application by 
shaving their backs with a small-animal fine clipper. They received the acryl- 
amide treatment once a day for 5 consecutive days. The acrylamide solution 
was applied to the lumbar region (backs of mice over abdomen) with a 
micropipett. A 30-g mouse received 100 ~1 of the solution, which spread 
over an area of approximately 5.4 cm2. Smaller mice received lesser volumes 
that were proportional to their weights. Each mouse was placed individually 
in a 4000-ml glass beaker after each dermal application for about 15 min 
to allow the back to dry. Prior to conducting the dominant lethal study, an 
acute toxicity experiment in which mice were observed for 30 days following 
the last day of treatment was conducted to determine the maximum tolerated 
dose under this condition. Doses of 200, 150, and 100 mg/kg/day were given 
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to 8 mice each and the numbers of survivors were 4, 7, and 8, respectively. 
Accordingly, the 125 mg/kg/day dose was chosen as the highest dose to use 
in the dominant lethal study. 
For the dominant lethal study, groups of 30 males were exposed to 125, 
100. 75, 50, or 25 mg/kg/day for 5 consecutive days. The dosing solutions 
were not analyzed for accuracy of the respective concentrations. Twenty- 
four males in each control group received the same volume of the carrier 
solution, which was 70% methanol, 30% water. Mice at the highest dose 
were used in the preliminary experiment. They were given the treatment 
beginning one day after shaving and they were returned to their cages im- 
mediately after the solution dried. Because of the positive effects observed 
at this dose, it was decided to modify the procedure for the main experiment 
to (a) ensure that the small skin abrasions caused by the clipper had healed 
prior to treatment and (b) minimize the possibility of oral ingestion of acryl- 
amide through licking of one’s or of each other’s back. Thus, treatment in 
the other dose groups started 4 days after shaving and, after the topically 
applied solutions had dried, they were restrained individually in tight plastic 
cubicles (originally designed to restrain mice during exposure to ionizing 
radiations) for at least 4 hr and then their backs washed in tap water with 
the aid of a soft brush before being caged together. No irritation of the skin 
was noticable in all treated groups at the end of the treatment period. 
Males were placed with untreated females from Days 7 through 10 fol- 
lowing the last exposure. This post-treatment interval was chosen on the 
basis of the study done earlier in this laboratory which showed that early 
spermatozoa and late spermatids, but not other stages, are the stages sensitive 
to induction of dominant lethal mutations with acrylamide (Shelby et al., 
1986). Females were examined each morning for the presence of vaginal 
plugs, which indicated that mating had occurred. Mated females were sep- 
arated from males immediately after finding a vaginal plug and uterine anal- 
yses were carried out I2- I4 days after observation of the vaginal plug. Data 
were obtained on the numbers of total implantations and living and dead 
implants. 
Data were pooled into two post-treatment mating intervals, 7-8 and 9- 
10 days. Tests for significance between experimental and control groups 
were performed on percentage dead implants, average number of living 
implants per pregnant female. and proportions of females with one or more 
dead implants. When appropriate, one-sided comparisons were made to 
identify specific directional departures from the no-effect hypothesis. For 
percentage dead implants, concern for overdispersion due to per-litter vari- 
ability precluded the use of simple analysis based on the binomial distribution 
(Haseman and Soares, 1976). Therefore, a nonparametric form of statistical 
bootstrapping in which the original data were resampled 4000 times via 
computer simulations was employed (Efron and Gong, 1983). The resulting 
bootstrap resamples were then used to estimate the standard errors of the 
observed percentages. Pairwise comparisons between any two percentages 
were assessed by a t statistic (Gladen, 1979). corrected for possible hetero- 
geneity in the estimated standard errors using a Satterthwaite adjustment 
to the t statistic’s degrees of freedom (Steel and Torrie, 1980. Chap. 5). The 
average number of living implants per pregnant female was also analyzed 
by calculating standard errors from bootstrap resamples. Pairwise compar- 
isons were based on differences in mean responses. Mean dose response was 
estimated via a linear least-squares model (Steel and Torrie, 1980, Chap. 
IO), with standard errors again calculated from the bootstrap resamples. To 
assess possible nonlinear departure from this linear model, a lack-of-fit statistic 
(Draper and Smith, 198 I) was calculated, wherein departure from the linear 
model is evidenced for large values of the statistic. The empirical probability 
of observing a departure as great or greater than that actually observed for 
each data set was also calculated from the bootstrap resamples. For proportion 
of females with one or more dead implants, one-sided pairwise comparisons 
were assessed by the statistic Z = w from the associated 2 X 2 table (Steel 
and Torrie. 1980. Chap. 22). 
RESULTS 
Results of uterine analysis of mated females are shown in 
Table 1. The incidence of dead implants and the proportion 
of pregnant females with one or more dead implants are 
significantly higher in each treated group than in the corre- 
sponding control group. Reductions in the number of living 
embryos were significant at all doses, except at the lowest 
(25 mg/kg). The effects of acrylamide on the numbers of 
living and dead embryos were generally higher at the matings 
at 7-8 days than the matings at 9-10 days. 
As a single descriptive measure of overall dominant lethal 
effects, the average number of living embryos per female is 
the most useful response variable. It reflects both pre- and 
postimplantation losses due to induced dominant lethality. 
However, in making comparisons it is necessary to take into 
account matings in which all of the conceptuses died prior 
to implantation, as in the case at the highest dose, where a 
reduced proportion of mated females had implants. Thus, 
the dose-response analysis was based on live and dead im- 
plants at the four lower doses at which the proportions of 
mated females with implants were apparently not affected 
by the treatments. The shape of the dose-effect curves for 
mean number of living embryos and percentage dead im- 
plants appear to be complementary for the two post-treat- 
ment mating periods (Fig. I). Tests for lack of linear fit in- 
dicate that the dose-response curves for the mean number 
of living embryos do not deviate significantly from linearity 
(bootstrap p = 0.082 and 0.236 for intervals 7-8 and 9-10 
days, respectively). It should be noted, however, that there 
is some overlap of confidence limits (Fig. 1) among but not 
between the three lowest and two highest treatment groups. 
DISCUSSION 
Dominant lethal mutations are genetic changes in parental 
germ cells that lead to death of first-generation carriers. In 
mice, death generally occurs at around the time of implan- 
tation, which is manifested in the uterus in the form of a 
resorption body. In severe cases, lethal mutations may be 
expressed in early cleavage stages whereupon the embryo is 
lost prior to implantation. The minimum conditions for a 
positive dominant lethal effect set by the International Com- 
mission for Protection against Environmental Mutagens and 
Carcinogens ( 1983) are a significant reduction in the average 
number of living embryos and a significant increase in either 
the average number of dead implantations or the number 
of females with one or more dead implants. All treatment 
groups met this condition with the exception of 25 mg/kg/ 
day (lowest dose used), at which no significant changes were 
induced in the mean number of living embryos per female. 
The lack of significance in this endpoint could be attributed 
to the small numbers of pregnancies analyzed. The significant 
trend in the dose response and the consistency in the control 
values for both the incidence of dead implants and the num- 
ber of females with one or more dead implants suggest an 
effect at the 25 mg/kg/day exposure. In contrast, none of the 
doses used show signs of neurotoxicity. 
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Thus, the results are consistent with a model whereby 
acrylamide was absorbed through the skin, and reached and 
affected early spermatozoa in epididymis and late spermatids 
in seminiferous tubules, causing dominant lethal mutations. 
Dominant lethal mutations induced by acrylamide, which 
are presumed to be caused by chromosome breakage effects 
(Shelby et al., 1986) have been found to be associated with 
the production of heritable translocations (Shelby et al., 
1987). The dose of 75 mg/kg/day in the present study induced 
70% dominant lethal mutations. From the earlier study in 
this laboratory (Shelby ef al., 1987), this level of dominant 
lethal mutations induced by intraperitoneal injections of 40 
mg/kg X 5 acrylamide is associated with 24% carriers of bal- 
anced reciprocal translocations among live progeny. Whether 
the shape of the dose-response curve for acrylamide-induced 
heritable translocations is similar to that for dominant lethals 
remains to be determined. A dose-effect study for intraper- 
itoneally injected acrylamide has not been done. Therefore, 
while it appears that intraperitoneal injection produced 
higher dominant lethal responses than dermal application, 
the magnitude of the difference and whether the difference 
is dose dependent are not known. 
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FIG. 1. Male mouse dominant lethal responses to acrylamide admin- 
istered topically. Mice were treated once a day for 5 consecutive days. Vertical 
bars represent 95% confidence intervals on mean or percentage response. 
Laboratory investigators and municipal sewer grout to-linear dose response implies that genetic damage may be 
workers (McHugh, 1987) are, in particular, exposed to acryl- produced at exposure levels much lower than the lowest dose 
amide primarily by the dermal route. In mice, acrylamide used in the present study, perhaps even down to the levels 
is readily absorbed through the skin and binds to DNA in that humans encounter in the workplace. This possibility 
the testes (Carlson and Weaver, 1985). The linear or close- needs to be resolved through a combined dominant lethal 
TABLE 1 
Summary Data from Dominant Lethal Studies in Male Mice Topically Exposed to Acrylamide 
Treatment 
Ow/k/dW’ 
Controld 
25 
50 
75 
100 
Control 
125 
Mating period 
(days) * 
7, 8 
9, 10 
7. 8 
9. 10 
7, 8 
9, 10 
7, 8 
9, 10 
7, 8 
9, 10 
7, 8 
9, 10 
7, 8 
9, 10 
Number of Number of 
mated pregnant 
females females 
31 36 
41 42 
21 19 
20 17 
21 20 
28 23 
24 21 
41 36 
18 17 
34 25 
10 9 
10 10 
17 9 
26 18 
Number of 
implantations 
per pregnant 
female 
10.6 
10.0 
10.8 
10.5 
9.9 
10.4 
1.5 
9.4 
7.3 
9.0 
11.1 
9.1 
5.4 
7.2 
Number of 
pregnant females 
with z 1 dead 
implant 
9 
11 
16’ 
13’ 
18’ 
22’ 
21’ 
30’ 
17’ 
23’ 
3 
ih 
18” 
Number of 
living embryos 
per pregnant 
female 
10.3 
9.6 
9.4 
9.5 
7.8f 
8.4g 
3.1e 
6.3’ 
1.7’ 
5.0’ 
10.7 
9.6 
l.Oh 
2.2h 
Dead 
implants 
(%) 
2.6 
3.6 
13.2’ 
9.Of 
21.7’ 
18.8’ 
59.2’ 
32.9e 
76.6’ 
45.1’ 
4.0 
1.0 
81.6h 
70.0h 
Dominant 
lethal? 
(%I 
10 
-8 
25 
4 
70 
38 
83 
49 
91 
77 
’ Once a day for 5 consecutive days. 
* After the last dose. 
’ Dominant lethals (%) = [ 1 - average number of living embryos (Treated)/average number of living embryos (Control)] X 100. 
d Data were pooled from two control groups. 
*,Jnp < 0.001, 0.0 1, and 0.05, respectively (after bootstrap comparison with pooled controls, unadjusted for multiple comparisons). 
h p 2 0.00 1 (after bootstrap comparison with concomitant control). 
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and heritable translocation study at low exposure levels ad- Draper, N.. and Smith, H. (1981). Applied Regression Analysis, 2nd ed., 
dressing all conditions of exoosure that are relevant to eval- Chap. 1. Wiley, New York. 
uation of risk. There are two obvious questions: (I) Is mouse Efron, B., and Gong, G. (1983). A leisurely look at the bootstrap, the jack- 
skin similar to human skin with respect to acrylamide ab- knife, and cross-validation. Am. Stat. 37, 36-48. 
sorption? (2) Do mice and humans metabolize/excrete Gladen, B. (1979). The use of the jackknife to estimate proportions from 
acrylamide in the same fashion? 
toxicological data in the presence of litter effects. J. Am. Statist. Assoc. 
74278-282. 
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